CHEMOMETRICS OPTIMIZED GREEN LIQUID CHROMATOGRAPHY METHOD FOR SIMULTANEOUS ESTIMATION OF PREGABALIN AND ETORICOXIB IN COMBINED TABLET FORMULATION

Q4 Pharmacology, Toxicology and Pharmaceutics INDIAN DRUGS Pub Date : 2023-07-28 DOI:10.53879/id.60.07.13380
S. Panda, Pratap C. Routa, R. Bera
{"title":"CHEMOMETRICS OPTIMIZED GREEN LIQUID CHROMATOGRAPHY METHOD FOR SIMULTANEOUS ESTIMATION OF PREGABALIN AND ETORICOXIB IN COMBINED TABLET FORMULATION","authors":"S. Panda, Pratap C. Routa, R. Bera","doi":"10.53879/id.60.07.13380","DOIUrl":null,"url":null,"abstract":"Pregabalin and etoricoxib have been recently approved as a potent fixed-dose combination to treat patients with neuropathic back pain effectively. The present investigation quantified both drugs by using a liquid chromatography method using principles of analytical quality-by-design. We assessed the risks, sorted critical method variables and studied their influence on critical analytical attributes using the BoxBehnken design. The optimal chromatographic solutions used acetonitrile: 10 mMol L-1 phosphate buffer of pH 3.51 (70:30 V/V) as the mobile phase. A C-18 column (250 mm × 4.6 mm, 5 µm) with mobile phase flow at 0.9 mL min-1 was used to achieve separation. The developed method's specificity, linearity, accuracy and precision were fair. Furthermore, the method was selective and recovered both analytes to their maximum extent. Additionally, the national environmental methods index approach revealed superior method greenness of the used method for routine quantification of pregabalin and etoricoxib from pharmaceutical samples.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INDIAN DRUGS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53879/id.60.07.13380","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Pregabalin and etoricoxib have been recently approved as a potent fixed-dose combination to treat patients with neuropathic back pain effectively. The present investigation quantified both drugs by using a liquid chromatography method using principles of analytical quality-by-design. We assessed the risks, sorted critical method variables and studied their influence on critical analytical attributes using the BoxBehnken design. The optimal chromatographic solutions used acetonitrile: 10 mMol L-1 phosphate buffer of pH 3.51 (70:30 V/V) as the mobile phase. A C-18 column (250 mm × 4.6 mm, 5 µm) with mobile phase flow at 0.9 mL min-1 was used to achieve separation. The developed method's specificity, linearity, accuracy and precision were fair. Furthermore, the method was selective and recovered both analytes to their maximum extent. Additionally, the national environmental methods index approach revealed superior method greenness of the used method for routine quantification of pregabalin and etoricoxib from pharmaceutical samples.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
化学计量学优化了同时测定复方普瑞巴林和依托昔布含量的绿色液相色谱法
普瑞巴林和依托瑞昔最近被批准为一种有效的固定剂量组合,可有效治疗神经性背痛患者。本研究采用液相色谱法,利用设计分析质量原理对两种药物进行定量。我们评估了风险,对关键方法变量进行了分类,并使用BoxBehnken设计研究了它们对关键分析属性的影响。最佳色谱溶液使用乙腈:10mmol L-1 pH为3.51(70:30 V/V)的磷酸盐缓冲液作为流动相。使用流动相流量为0.9 mL min-1的C-18柱(250 mm×4.6 mm,5µm)进行分离。该方法具有良好的特异性、线性、准确度和精密度。此外,该方法具有选择性,并最大限度地回收了两种分析物。此外,国家环境方法指数法显示,所用方法在药物样品中常规定量普瑞巴林和依托里昔布时具有良好的方法绿色性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
INDIAN DRUGS
INDIAN DRUGS Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
0.30
自引率
0.00%
发文量
98
期刊最新文献
COMPUTATIONAL IDENTIFICATION OF SELECTED BIOACTIVE COMPOUNDS FROM CEDRUS DEODARA AS INHIBITORS AGAINST SARS-COV-2 MAIN PROTEASE: A PHARMACOINFORMATICS STUDY PREPARATION AND CHARACTERIZATION OF MICROSPHERES UTILIZING RATE-CONTROLLING MEMBRANES FOR THE MANAGEMENT OF DIABETES MELLITUS PHYSICOCHEMICAL AND PHARMACOKINETIC ANALYSIS AND DOCKING OF DRUG REPOSITIONING AGAINST SARS-COV-2: AN IN SILICO STUDY NEED/ROLE OF GENERATIVE AI IN PHARMACEUTICAL RESEARCH THE GENUS LITSEA: A REVIEW OF ITS CYTOTOXIC POTENTIAL AND PHYTOCHEMISTRY
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1